{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:42:47Z","timestamp":1791726167691,"version":"4.3.4"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Context<\/jats:title><jats:p>Cushing\u2019s syndrome (CS) is a rare disease of endogenous hypercortisolism associated with high morbidity and mortality. Diagnosis and classification of CS is still challenging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>Circulating microRNAs (miRNAs) are minimally invasive diagnostic markers. Our aim was to characterize the circulating miRNA profiles of CS patients and to identify distinct profiles between the two major CS subtypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included three groups of patients from the German Cushing\u2019s registry: ACTH-independent CS (Cortisol-Producing-Adenoma; CPA), ACTH-dependent pituitary CS (Cushing\u2019s Disease; CD), and patients in whom CS had been ruled out (controls). Profiling of miRNAs was performed by next-generation-sequencing (NGS) in serum samples of 15 CS patients (each before and after curative surgery) and 10 controls. Significant miRNAs were first validated by qPCR in the discovery cohort and then in an independent validation cohort of 20 CS patients and 11 controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>NGS identified 411 circulating miRNAs. Differential expression of 14 miRNAs were found in the pre- and postoperative groups. qPCR in the discovery cohort validated 5 of the significant miRNAs from the preoperative group analyses. Only, miR-182-5p was found to be significantly upregulated in the CD group of the validation cohort. Comparing all CS samples as a group with the controls did not reveal any significant differences in expression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcome<\/jats:title><jats:p>In conclusion, our study identified miR-182-5p as a possible biomarker for CD, which has to be validated in a prospective cohort. Furthermore, our results suggest that presence or absence of ACTH might be at least as relevant for miRNA expression as hypercortisolism itself.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.620012","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T05:42:49Z","timestamp":1613972569000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Circulating microRNA Expression in Cushing\u2019s Syndrome"],"prefix":"10.3389","volume":"12","author":[{"given":"Sharmilee","family":"Vetrivel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareen","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Osswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silviu","family":"Sbiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Riester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/ijms18020294","article-title":"Metabolomic biomarkers in urine of Cushing\u2019s syndrome patients","volume":"18","author":"Kot\u0142owska","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1159\/000134829","article-title":"Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin-independent Cushing syndrome)","volume":"13","author":"Stratakis","year":"2008","journal-title":"Endocr Dev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"bcr2017220154","DOI":"10.1136\/bcr-2017-220154","article-title":"Primary bilateral adrenal nodular disease with Cushing\u2019s syndrome: Varying aetiology","volume":"2017","author":"Jarial","year":"2017","journal-title":"BMJ Case Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000134829","article-title":"Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin-independent Cushing syndrome)","volume":"13","author":"Stratakis","year":"2008","journal-title":"Endocr Dev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-1095","article-title":"The burden of Cushing\u2019s disease: Clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to Diagnosis in Cushing\u2019s Syndrome: A Meta-Analysis Based on 5367 Patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0464","article-title":"High mortality within 90 days of diagnosis in patients with Cushing\u2019s syndrome: results from the ERCUSYN registry","volume":"181","author":"Valassi","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B8","article-title":"mRNA and microRNA expression patterns in adrenocortical cancer","volume":"1","author":"Zsippai","year":"2011","journal-title":"Am J Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in Cancer: Potential and Challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1647","article-title":"Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)","volume":"41","author":"Allegra","year":"2012","journal-title":"Int J Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1756-9966-31-38","article-title":"Circulating microRNAs in cancer: Origin, function and application","volume":"31","author":"Ma","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.04.128","article-title":"Evaluation of the performance of serum miRNAs as normalizers in microRNA studies focused on cardiovascular disease","volume":"10","author":"Wang","year":"2018","journal-title":"J Thorac Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00195","article-title":"MicroRNAs as potential biomarkers in adrenocortical cancer: Progress and challenges","volume":"6","author":"Cherradi","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/cancers12020461","article-title":"Non-coding RNAs in adrenocortical cancer: From pathogenesis to diagnosis","volume":"12","author":"Decmann","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0817","article-title":"MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas","volume":"170","author":"Vel\u00e1zquez-Fern\u00e1ndez","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.06.022","article-title":"MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors","volume":"154","author":"Patel","year":"2013","journal-title":"Surg (U S)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00331","article-title":"Circulating Plasma microRNA to Differentiate Cushing's Disease From Ectopic ACTH Syndrome","volume":"11","author":"Belaya","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz415","article-title":"SRNAbench and sRNAtoolbox 2019: intuitive fast small RNA profiling and differential expression","volume":"47","author":"Aparicio-Puerta","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: A Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2009","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10620-011-1981-7","article-title":"Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients","volume":"57","author":"Song","year":"2012","journal-title":"Dig Dis Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2013.148","article-title":"Analysis of circulating microRNAs in adrenocortical tumors","volume":"94","author":"Szab\u00f3","year":"2014","journal-title":"Lab Investig"},{"key":"B26","article-title":"Supplementary data from: Circulating microRNA Expression in Cushing\u2019s Syndrome","volume-title":"Figshare","author":"Vetrivel","year":"2020"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-019-0538-y","article-title":"Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia","volume":"9","author":"Hu","year":"2019","journal-title":"Transl Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-60618-x","article-title":"Impact of different stabilization methods on RT-qPCR results using human lung tissue samples","volume":"10","author":"Esteva-Socias","year":"2020","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00739","article-title":"Circulating miRNA Expression Profiling in Primary Aldosteronism","volume":"10","author":"Gray","year":"2019","journal-title":"Front Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00766","article-title":"Toward a Diagnostic Score in Cushing\u2019s Syndrome","volume":"10","author":"Braun","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.92","article-title":"Endocrine incidentalomas Challenges imposed by incidentally discovered lesions","volume":"7","author":"Vassiliadi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ando.2015.04.004","article-title":"Management of nonfunctioning pituitary incidentaloma","volume":"76","author":"Galland","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cells9020276","article-title":"miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00739","article-title":"Circulating miRNA Expression Profiling in Primary Aldosteronism","volume":"10","author":"Decmann","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2245","article-title":"Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression","volume":"5","author":"Perilli","year":"2014","journal-title":"Oncotarget"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.05.24","article-title":"Circulating miR-182-5p and miR-5187-5p as biomarkers for the diagnosis of unprotected left main coronary artery disease","volume":"11","author":"Zhu","year":"2019","journal-title":"J Thorac Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ18-0487","article-title":"Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas","volume":"66","author":"He","year":"2019","journal-title":"Endocr J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/2211068214561788","article-title":"Technology in MicroRNA Profiling: Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer","volume":"20","author":"Pimentel","year":"2015","journal-title":"J Lab Autom"},{"key":"B39","unstructured":"The microRNA-183 Cluster: The Family That Plays Together Stays Together."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-11-0308","article-title":"The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma","volume":"19","author":"Patterson","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1285","article-title":"ACTH-dependent regulation of MicroRNA as endogenous modulators of glucocorticoid receptor expression in the adrenal gland","volume":"153","author":"Riester","year":"2012","journal-title":"Endocrinology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078040","article-title":"Hormonal Regulation of MicroRNA Expression in Steroid Producing Cells of the Ovary, Testis and Adrenal Gland","volume":"8","author":"Hu","year":"2013","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-017-0078-4","article-title":"Mutant Runx2 regulates amelogenesis and osteogenesis through a miR-185-5p-Dlx2 axis article","volume":"8","author":"Chang","year":"2017","journal-title":"Cell Death Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.620012\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T05:42:53Z","timestamp":1613972573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.620012\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":43,"alternative-id":["10.3389\/fendo.2021.620012"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.620012","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"article-number":"620012"}}